French pharmaceutical company SGH Medical Pharma has officially opened its factory in Mégrine, Tunisia. The 3000m² facility, which includes clean rooms, marks the company's first international expansion. The project was announced in 2024, and its completion signifies a significant milestone for SGH Medical Pharma. The factory's operations will contribute to Tunisia's economy and provide new employment opportunities.
The factory's inauguration on October 1, 2026, confirms the progress made by SGH Medical Pharma in establishing its presence in Tunisia. According to the French Treasury Department, the facility meets the necessary standards for pharmaceutical production. This development demonstrates the company's commitment to expanding its operations beyond France. The choice of Tunisia as the site for its first international factory reflects the country's growing appeal to foreign investors.
Initially, the project was expected to create 60 jobs, but the number of employees has been revised upward to approximately 100. This represents a significant increase of nearly two-thirds compared to the initial target. The growth in employment opportunities highlights the project's expanded scope and its potential impact on the local job market. The factory's workforce will play a crucial role in the production of pharmaceutical products.
The investment by SGH Medical Pharma in Tunisia underscores the country's efforts to attract foreign investment and promote economic growth. The factory's establishment is expected to have a positive effect on the local economy and contribute to the country's industrial development. The project aligns with Tunisia's goals of diversifying its economy and increasing its appeal to international investors.
In April 2024, it was announced that SGH Medical Pharma had chosen Tunisia as the location for its first international factory. Two years later, the project has come to fruition with the inauguration of the factory. The company's decision to invest in Tunisia reflects its confidence in the country's business environment and its potential for growth.
The factory in Mégrine is equipped with state-of-the-art facilities, including clean rooms, which are essential for pharmaceutical production. The company's investment in this infrastructure demonstrates its commitment to quality and regulatory compliance. The facility will enable SGH Medical Pharma to produce high-quality pharmaceutical products that meet international standards.
The inauguration of the SGH Medical Pharma factory in Mégrine marks a significant milestone in the company's expansion plans. With a workforce of approximately 100 employees, the factory is poised to make a positive impact on the local economy and contribute to Tunisia's industrial development. The project's success will depend on various factors, including the company's ability to maintain high production standards and adapt to changing market conditions.
Key points
- SGH Medical Pharma's factory in Tunisia will employ approximately 100 people.
- The factory in Mégrine is SGH Medical Pharma's first international expansion.
- The facility was officially inaugurated on October 1, 2026.
